María de Lourdes Mora‐García

Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid

María de Lourdes Mora‐García, Alfonso Dueñas‐González, Jorge Hernández‐Montes et al. · Journal of Translational Medicine · 2006 · 73 citations · Full text

Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions

María de Lourdes Mora‐García, Rosario García‐Rocha, Omar Morales-Ramírez et al. · Journal of Translational Medicine · 2016 · 73 citations · Full text

An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice

Georgina Paz de la Rosa, Alberto Monroy, María de Lourdes Mora‐García et al. · Virology Journal · 2009 · 71 citations · Full text

In Vitro Evidence of the Presence of Mesenchymal Stromal Cells in Cervical Cancer and Their Role in Protecting Cancer Cells from Cytotoxic T Cell Activity

Juan José Montesinos, María de Lourdes Mora‐García, Héctor Mayani et al. · Stem Cells and Development · 2013 · 57 citations · Full text

Mesenchymal stromal cells derived from cervical cancer tumors induce TGF-β1 expression and IL-10 expression and secretion in the cervical cancer cells, resulting in protection from cytotoxic T cell activity

Rosario García‐Rocha, Martha C. Moreno‐Lafont, María de Lourdes Mora‐García et al. · Cytokine · 2015 · 41 citations

Cancer Immunosurveillance, Il-10 Expression, Cervical Cancer +11